Brief: Regulus Therapeutics Reports Third Quarter 2022 Financial Results And Recent Updates
Nov 10 (Reuters) - Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND RECENT UPDATES
* REGULUS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.50
Source text for Eikon: ID:nPnbhwZS1a
Further company coverage: RGLS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview